| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0002 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |